These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 29948585)

  • 1. Evaluation of right ventricular pacing parameters in patients with proliferative scar.
    Vurgun VK; Baskovski E; Goksuluk H; Ozyuncu N; Tan TS; Altin AT; Candemir B; Akyurek O
    J Interv Card Electrophysiol; 2018 Nov; 53(2):249-254. PubMed ID: 29948585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Parameters of cardiac pacing and effectiveness of defibrillation during implantable cardioverter-defibrillator lead implantation to right ventricle outflow tract].
    Rydlewska A; Machejek J; Engel A; Lelakowski J
    Pol Merkur Lekarski; 2013 Nov; 35(209):254-8. PubMed ID: 24575643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence, management, and prevention of right ventricular perforation by pacemaker and implantable cardioverter defibrillator leads.
    Migliore F; Zorzi A; Bertaglia E; Leoni L; Siciliano M; De Lazzari M; Ignatiuk B; Veronese M; Verlato R; Tarantini G; Iliceto S; Corrado D
    Pacing Clin Electrophysiol; 2014 Dec; 37(12):1602-9. PubMed ID: 25131984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complications of permanent cardiac pacing in patients with persistent left superior vena cava.
    Polewczyk A; Kutarski A; Czekajska-Chehab E; Adamczyk P; Boczar K; Polewczyk M; Janion M
    Cardiol J; 2014; 21(2):128-37. PubMed ID: 24526508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term right ventricular implantable cardioverter-defibrillator lead performance in arrhythmogenic right ventricular cardiomyopathy.
    Herman AR; Gardner M; Steinberg C; Yeung-Lai-Wah JA; Healey JS; Leong-Sit P; Krahn AD; Chakrabarti S
    Heart Rhythm; 2016 Oct; 13(10):1964-70. PubMed ID: 27321245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and predictors of clinically relevant cardiac perforation associated with systematic implantation of active-fixation pacing and defibrillation leads: a single-centre experience with over 3800 implanted leads.
    Cano Ó; Andrés A; Alonso P; Osca J; Sancho-Tello MJ; Olagüe J; Martínez-Dolz L
    Europace; 2017 Jan; 19(1):96-102. PubMed ID: 26847075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of basic electrical features of ICD defibrillating leads implanted to right ventricular apex or right ventricular outflow track and septum].
    Szafraniec Z; Kaczmarek K; Pałka K; Ptaszyński P; Ruta J; Chudzik M; Wranicz JK
    Pol Merkur Lekarski; 2014 Mar; 36(213):155-9. PubMed ID: 24779211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical safety of an MRI conditional implantable cardioverter defibrillator system: A prospective Monocenter ICD-Magnetic resonance Imaging feasibility study (MIMI).
    Kypta A; Blessberger H; Hoenig S; Saleh K; Lambert T; Kammler J; Fellner F; Lichtenauer M; Steinwender C
    J Magn Reson Imaging; 2016 Mar; 43(3):574-84. PubMed ID: 26335332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An observational study of the effect of coronary artery disease severity on acute pacing threshold and lead impedance in patients with permanent pacemaker.
    Ekinci S; Yeşil M; Bayata S; Arikan E; Vurgun VK; Postaci N; Safak O; Ozdemir E
    Anadolu Kardiyol Derg; 2012 May; 12(3):208-13. PubMed ID: 22366104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pacing and implantable cardioverter defibrillator lead perforation as assessed by multiplanar reformatted ECG-gated cardiac computed tomography and clinical correlates.
    Pang BJ; Lui EH; Joshi SB; Tacey MA; Alison J; Seneviratne SK; Cameron JD; Mond HG
    Pacing Clin Electrophysiol; 2014 May; 37(5):537-45. PubMed ID: 24883448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcutaneous lead implantation connected to an externalized pacemaker in patients with implantable cardiac defibrillator/pacemaker infection and pacemaker dependency.
    Pecha S; Aydin MA; Yildirim Y; Sill B; Reiter B; Wilke I; Reichenspurner H; Treede H
    Europace; 2013 Aug; 15(8):1205-9. PubMed ID: 23426553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator.
    Gardiwal A; Yu H; Oswald H; Luesebrink U; Ludwig A; Pichlmaier AM; Drexler H; Klein G
    Europace; 2008 Mar; 10(3):358-63. PubMed ID: 18308756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term safety and efficacy of right ventricular outflow tract pacing in patients with permanent pacemakers.
    Erdoğan O; Aktöz M; Altun A
    Anadolu Kardiyol Derg; 2008 Oct; 8(5):350-3. PubMed ID: 18849226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eligibility of Pacemaker Patients for Subcutaneous Implantable Cardioverter Defibrillators.
    Ip JE; Wu MS; Kennel PJ; Thomas G; Liu CF; Cheung JW; Markowitz SM; Lerman BB
    J Cardiovasc Electrophysiol; 2017 May; 28(5):544-548. PubMed ID: 28185354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of right ventricular apical pacing with transvenous pacemaker and implantable cardioverter defibrillator on mitral and tricuspid regurgitation.
    Fanari Z; Hammami S; Hammami MB; Hammami S; Shuraih M
    J Electrocardiol; 2015; 48(5):791-7. PubMed ID: 26216371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ventricular pacing lead position on tricuspid regurgitation: A randomized prospective trial.
    Schleifer JW; Pislaru SV; Lin G; Powell BD; Espinosa R; Koestler C; Thome T; Polk L; Li Z; Asirvatham SJ; Cha YM
    Heart Rhythm; 2018 Jul; 15(7):1009-1016. PubMed ID: 29496605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal Outcomes of Epicardial and Endocardial Pacemaker Leads in the Adult Fontan Patient.
    Huntley GD; Deshmukh AJ; Warnes CA; Kapa S; Egbe AC
    Pediatr Cardiol; 2018 Oct; 39(7):1476-1483. PubMed ID: 29948032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Very late effects of dual chamber pacing therapy for obstructive hypertrophic cardiomyopathy.
    Lucon A; Palud L; Pavin D; Donal E; Behar N; Leclercq C; Mabo P; Daubert JC
    Arch Cardiovasc Dis; 2013; 106(6-7):373-81. PubMed ID: 23806305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic transvenous pacemaker/implantable cardioverter defibrillator leads implantation induced pathological changes].
    Li Y; Dykoski R; Li J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2015 May; 43(5):423-7. PubMed ID: 26419988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between ventricular pacing and persistent atrial fibrillation in patients indicated to elective pacemaker replacement: Results of the Prefer for Elective Replacement MVP (PreFER MVP) randomized study.
    Ricci RP; Botto GL; Bénézet JM; Nielsen JC; De Roy L; Piot O; Quesada A; Quaglione R; Vaccari D; Mangoni L; Grammatico A; Kozák M;
    Heart Rhythm; 2015 Nov; 12(11):2239-46. PubMed ID: 26142300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.